Which cognitive domains are improved by treatment with vortioxetine?

50Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: These post hoc analyses evaluated vortioxetine efficacy on cognitive dysfunction in depression. Data were from a double-blind, randomized, fixed-dose, placebo-controlled, 8-week depression study in adults aged 18-65 years (n = 602) with DSMIV- defined major depressive disorder (MDD). Subjects were randomized (1:1:1) to vortioxetine 10 mg/day or 20 mg/day or placebo. Methods: Cognitive function was assessed at baseline, Week 1 (10 mg/day only) and Week 8 using Digit Symbol Substitution Test (DSST) number of correct symbols, Rey Auditory Verbal Learning Test, Trail Making Test, Stroop test, Simple Reaction Time, and Choice Reaction Time tests. The cognition variables were standardized and used for constructing composite Z-scores for the cognitive domains of executive function, attention/speed of processing, and memory. Results: At Week 1, vortioxetine 10 mg/day separated from placebo for attention/speed of processing (standardized composite Z-score = 0.21; p = 0.0238) and DSST number of correct symbols (standardized effect size = 0.18; p = 0.0458) and for executive function (standardized composite Z-score = 0.20; p = 0.0274). At Week 8, vortioxetine 10 mg/day and 20 mg/day separated from placebo for executive function and attention/speed of processing, with standardized composite Z-scores ranging from 0.35 to 0.49 (all p < 0.01). Standardized composite Z-scores for memory were 0.31 (p = 0.0036, 10 mg/day) and 0.22 (p = 0.0349, 20 mg/ day). Standardized effect sizes for DSST were 0.51 (p < 0.0001, 10 mg/day) and 0.52 (p < 0.0001, 20 mg/day). Results are limited by the post hoc nature of the analyses and the absence of an active reference in the original study. Conclusions: Vortioxetine (10 and 20 mg/day) had a multi-domain beneficial effect on cognitive performance, as evidenced by improvements in measures of executive function, attention/speed of processing, and memory. The effect on the DSST may be due to improvements in several cognitive skills.

References Powered by Scopus

Cognitive dysfunction in psychiatric disorders: Characteristics, causes and the quest for improved therapy

962Citations
N/AReaders
Get full text

A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder

627Citations
N/AReaders
Get full text

Cognitive deficits and functional outcomes in major depressive disorder: Determinants, substrates, and treatment interventions

624Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cognitive dysfunction in major depressive disorder

157Citations
N/AReaders
Get full text

Advances in antidepressants for treating post-stroke depression

91Citations
N/AReaders
Get full text

Advancing Translational Research Using NIMH Research Domain Criteria and Computational Methods

75Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Harrison, J. E., Lophaven, S., & Olsen, C. K. (2016). Which cognitive domains are improved by treatment with vortioxetine? International Journal of Neuropsychopharmacology, 19(10), 1–6. https://doi.org/10.1093/ijnp/pyw054

Readers over time

‘16‘17‘18‘19‘20‘21‘22‘23‘2406121824

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 27

56%

Researcher 14

29%

Professor / Associate Prof. 5

10%

Lecturer / Post doc 2

4%

Readers' Discipline

Tooltip

Neuroscience 18

38%

Medicine and Dentistry 16

34%

Psychology 12

26%

Pharmacology, Toxicology and Pharmaceut... 1

2%

Article Metrics

Tooltip
Mentions
News Mentions: 1
Social Media
Shares, Likes & Comments: 14

Save time finding and organizing research with Mendeley

Sign up for free
0